Display options
Cite
Flaherty K. Advances in drug development. BRAF validation in melanoma. Clin Adv Hematol Oncol. 2010;8(1):31-4
Flaherty, K. (2010). Advances in drug development. BRAF validation in melanoma. Clinical advances in hematology & oncology : H&O, 8(1), 31-4.
Flaherty, Keith. "Advances in drug development. BRAF validation in melanoma." Clinical advances in hematology & oncology : H&O vol. 8,1 (2010): 31-4.
Flaherty K. Advances in drug development. BRAF validation in melanoma. Clin Adv Hematol Oncol. 2010 Jan;8(1):31-4. PMID: 20351680.
Copy Download .nbib Format: NLM
Share it on

Clin Adv Hematol Oncol. 2010 Jan;8(1):31-4.

Advances in drug development. BRAF validation in melanoma.

Clinical advances in hematology & oncology : H&O

Keith Flaherty

Affiliations

  1. Massachusetts General Hospital, Boston, MA 02114, USA.

PMID: 20351680

[No abstract available.]

Substances

MeSH terms

Publication Types